Showing 1-7 of 7 results for "I1783"
Antonino Belfiore et al.
Endocrine-related cancer, 18(4), R125-R147 (2011-05-25)
The widespread epidemic of obesity and type 2 diabetes has raised concern for the impact of these disorders as risk factors for cancer and has renewed the interest for studies regarding the involvement of hyperinsulinemia and insulin receptor (IR) in...
Y Kido et al.
The Journal of clinical endocrinology and metabolism, 86(3), 972-979 (2001-03-10)
The pleiotropic actions of insulin are mediated by a single receptor tyrosine kinase. Structure/function relationships of the insulin receptor have been conclusively established, and the early steps of insulin signaling are known in some detail. A generally accepted paradigm is...
V Papa et al.
The Journal of clinical investigation, 86(5), 1503-1510 (1990-11-01)
The growth of breast cancer cells is under the regulation of hormones, growth factors, and their receptors. In the present study, we have employed a new, sensitive, and specific radioimmunoassay for the direct measurement of insulin receptors in surgical specimens...
Shailendra P Singh et al.
Journal of immunology (Baltimore, Md. : 1950), 201(5), 1491-1499 (2018-07-25)
A link between obesity and periodontitis has been suggested because of compromised immune response and chronic inflammation in obese patients. In this study, we evaluated the anti-inflammatory properties of Kavain, an extract from Piper methysticum, on Porphyromonas gingivalis-induced inflammation in...
V Papa et al.
Trends in endocrinology and metabolism: TEM, 8(8), 306-312 (2008-04-15)
It is commonly believed that the insulin receptor mainly mediates the metabolic effects of insulin, whereas the closely related IGF-I receptor is considered a major factor for the regulation of cell proliferation. Experimental and epidemiological evidence indicates, however, that insulin...
Ankit Gilani et al.
Prostaglandins & other lipid mediators, 152, 106485-106485 (2020-10-05)
20-HETE, a metabolite of arachidonic acid produced by Cytochrome P450 (CYP) 4A/4 F, has been implicated in the development of obesity-associated complications such as diabetes and insulin resistance. In this study, we examined whether the acute elevation of 20-HETE levels...

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.